Calcium phosphate-based cements: clinical needs and recent progress

Synthetic bone graft materials are actively pursued to address limitations of autografts. Prior research has shown that autografts, while effective, come with donor site complications. This gap motivated exploration of alternatives like calcium phosphate cements (CPCs). CPCs offer biocompatibility and osteoconductivity, making them promising candidates. However, their clinical adoption remains limited by unresolved issues. No prior work had resolved the balance between mechanical strength and injectability in CPCs. Researchers have already demonstrated CPCs' ability to harden in situ, but long-term performance remains unclear. This uncertainty drives the need for new CPC formulations that better meet clinical demands.

This review article aims to summarize recent advancements in CPC development. It addresses the clinical challenges that hinder widespread adoption of CPCs. The study focuses on how new CPC formulations address current limitations. By analyzing recent literature, the authors seek to highlight emerging solutions. They also emphasize the importance of tailoring CPC properties to specific applications. The review may suggest that CPCs could be optimized for load-bearing versus non-load-bearing defects. It proposes that understanding clinical needs is essential for guiding material design. The authors aim to bridge the gap between material science and clinical outcomes.

The authors conducted a comprehensive review of recent studies on CPCs. They synthesized findings from clinical trials and material science investigations. The review approach included evaluating CPC formulations and their clinical performance. Key findings from the literature were organized by theme and application area. The authors compared traditional CPCs with newer, modified versions. They analyzed how each modification addresses specific clinical challenges. The review also examined the impact of CPC composition on mechanical properties. The synthesis and implications section highlights unresolved issues and future directions.

Recent studies show that CPCs can be modified to improve injectability and mechanical strength. Some formulations incorporate additives to enhance setting time and compressive strength. Researchers have proposed using nanostructured particles to improve CPC performance. The review suggests that CPCs with tailored porosity may better support bone regeneration. Clinical trials indicate that CPCs are suitable for filling bone voids in non-weight-bearing areas. However, CPCs remain suboptimal for load-bearing applications due to insufficient mechanical strength. The authors propose that hybrid CPCs may offer a solution to this limitation. These findings may suggest that CPCs could be more widely adopted in specific clinical contexts.

The authors conclude that CPCs have made significant progress in addressing clinical needs. They emphasize that CPCs remain a viable alternative to autografts for certain applications. The review suggests that CPCs may be particularly useful in non-load-bearing bone defects. However, the authors propose that further improvements are needed for load-bearing applications. They highlight the importance of tailoring CPC properties to specific clinical scenarios. The authors may suggest that future research should focus on optimizing CPC formulations. They also propose that collaboration between material scientists and clinicians is essential. These conclusions align with the findings presented in the literature review.